Works matching IS 00070920 AND DT 2023 AND VI 129 AND IP 5

Results: 16

Can TILs supplement the TNM staging system (as TNM-Immune)?

Published in:

2023

By:

Almangush, Alhadi;
Mäkitie, Antti A.;
Leivo, Ilmo

Publication type:

Letter

Colorectal cancer detected by liquid biopsy 2 years prior to clinical diagnosis in the HUNT study.

Published in:

British Journal of Cancer, 2023, v. 129, n. 5, p. 861, doi. 10.1038/s41416-023-02337-4

By:

Brenne, Siv S.;
Madsen, Poul Henning;
Pedersen, Inge Søkilde;
Hveem, Kristian;
Skorpen, Frank;
Krarup, Henrik Bygum;
Giskeødegård, Guro F.;
Laugsand, Eivor A.

Publication type:

Article

Improving communication of cancer survival statistics—feasibility of implementing model-based algorithms in routine publications.

Published in:

British Journal of Cancer, 2023, v. 129, n. 5, p. 819, doi. 10.1038/s41416-023-02360-5

By:

Myklebust, Tor Åge;
Aagnes, Bjarte;
Nilssen, Yngvar;
Rutherford, Mark;
Lambert, Paul C.;
Andersson, Therese M. L.;
Johansson, Anna L. V.;
Dickman, Paul W.;
Møller, Bjørn

Publication type:

Article

Diagnostic yield of a risk model versus faecal immunochemical test only: a randomised controlled trial in a colorectal cancer screening programme.

Published in:

British Journal of Cancer, 2023, v. 129, n. 5, p. 791, doi. 10.1038/s41416-023-02358-z

By:

Kortlever, Tim L.;
van der Vlugt, Manon;
Duijkers, Floor A. M.;
Masclee, Ad;
Kraaijenhagen, Roderik;
Spaander, Manon C. W.;
Lansdorp-Vogelaar, Iris;
Bossuyt, Patrick M.;
Dekker, Evelien

Publication type:

Article

Exposure to benzene and other hydrocarbons and risk of bladder cancer among male offshore petroleum workers.

Published in:

British Journal of Cancer, 2023, v. 129, n. 5, p. 838, doi. 10.1038/s41416-023-02357-0

By:

Shala, Nita K.;
Stenehjem, Jo S.;
Babigumira, Ronnie;
Liu, Fei-Chih;
Berge, Leon A. M.;
Silverman, Debra T.;
Friesen, Melissa C.;
Rothman, Nathaniel;
Lan, Qing;
Hosgood, H. Dean;
Samuelsen, Sven O.;
Bråtveit, Magne;
Kirkeleit, Jorunn;
Andreassen, Bettina K.;
Veierød, Marit B.;
Grimsrud, Tom K.

Publication type:

Article

A Phase 1/2A trial of idroxioleic acid: first-in-class sphingolipid regulator and glioma cell autophagy inducer with antitumor activity in refractory glioma.

Published in:

British Journal of Cancer, 2023, v. 129, n. 5, p. 811, doi. 10.1038/s41416-023-02356-1

By:

Lopez, Juanita;
Lai-Kwon, Julia;
Molife, Rhoda;
Welsh, Liam;
Tunariu, Nina;
Roda, Desamparados;
Fernández-García, Paula;
Lladó, Victoria;
McNicholl, Adrian G.;
Rosselló, Catalina A.;
Taylor, Richard J.;
Azaro, Analía;
Rodón, Jordi;
Sludden, Julieann;
Veal, Gareth J.;
Plummer, Ruth;
Urruticoechea, Ander;
Lahuerta, Ainhara;
Mujika, Karmele;
Escribá, Pablo V.

Publication type:

Article

A real-world study of the first use of palbociclib for the treatment of advanced breast cancer within the UK National Health Service as part of the novel Ibrance® Patient Program.

Published in:

British Journal of Cancer, 2023, v. 129, n. 5, p. 852, doi. 10.1038/s41416-023-02352-5

By:

Palmieri, Carlo;
Musson, Alison;
Harper-Wynne, Catherine;
Wheatley, Duncan;
Bertelli, Gianfilippo;
Macpherson, Iain R.;
Nathan, Mark;
McDowall, Ellie;
Bhojwani, Ajay;
Verrill, Mark;
Eva, Joe;
Doody, Colm;
Chowdhury, Ruhe

Publication type:

Article

Nicardipine is a putative EED inhibitor and has high selectivity and potency against chemoresistant prostate cancer in preclinical models.

Published in:

British Journal of Cancer, 2023, v. 129, n. 5, p. 884, doi. 10.1038/s41416-023-02359-y

By:

Li, Xin;
Chen, Yanhua;
Bai, Lijuan;
Zhao, Rui;
Wu, Yifei;
Xie, Zhong-Ru;
Wu, Jason M.;
Bowen, Nathan J.;
Danaher, Alira;
Cook, Nicholas;
Li, Dehong;
Qui, Min;
Du, Yuhong;
Fu, Haian;
Osunkoya, Adeboye O.;
Kucuk, Omer;
Wu, Daqing

Publication type:

Article

Combination of pembrolizumab and pelareorep promotes anti-tumour immunity in advanced pancreatic adenocarcinoma (PDAC).

Published in:

British Journal of Cancer, 2023, v. 129, n. 5, p. 782, doi. 10.1038/s41416-023-02344-5

By:

Mahalingam, Devalingam;
Chen, Siqi;
Xie, Ping;
Loghmani, Houra;
Heineman, Thomas;
Kalyan, Aparna;
Kircher, Sheetal;
Helenowski, Irene B.;
Mi, Xinlei;
Maurer, Victoria;
Coffey, Matt;
Mulcahy, Mary;
Benson, Al-;
Zhang, Bin

Publication type:

Article

Chronic oxidative stress adaptation in head and neck cancer cells generates slow-cyclers with decreased tumour growth in vivo.

Published in:

British Journal of Cancer, 2023, v. 129, n. 5, p. 869, doi. 10.1038/s41416-023-02343-6

By:

Berner, Julia;
Miebach, Lea;
Kordt, Marcel;
Seebauer, Christian;
Schmidt, Anke;
Lalk, Michael;
Vollmar, Brigitte;
Metelmann, Hans-Robert;
Bekeschus, Sander

Publication type:

Article

MiR-662 is associated with metastatic relapse in early-stage breast cancer and promotes metastasis by stimulating cancer cell stemness.

Published in:

British Journal of Cancer, 2023, v. 129, n. 5, p. 754, doi. 10.1038/s41416-023-02340-9

By:

Puppo, Margherita;
Valluru, Manoj Kumar;
Croset, Martine;
Ceresa, Davide;
Iuliani, Michele;
Khan, Ashrin;
Wicinski, Julien;
Charafe-Jauffret, Emmanuelle;
Ginestier, Christophe;
Pantano, Francesco;
Ottewell, Penelope Dawn;
Clézardin, Philippe

Publication type:

Article

The underestimated impact of excess body weight on colorectal cancer risk: Evidence from the UK Biobank cohort.

Published in:

British Journal of Cancer, 2023, v. 129, n. 5, p. 829, doi. 10.1038/s41416-023-02351-6

By:

Safizadeh, Fatemeh;
Mandic, Marko;
Pulte, Dianne;
Niedermaier, Tobias;
Hoffmeister, Michael;
Brenner, Hermann

Publication type:

Article

Pamiparib in combination with tislelizumab in patients with advanced solid tumours: results from the dose-expansion stage of a multicentre, open-label, phase I trial.

Published in:

British Journal of Cancer, 2023, v. 129, n. 5, p. 797, doi. 10.1038/s41416-023-02349-0

By:

Friedlander, Michael;
Mileshkin, Linda;
Lombard, Janine;
Frentzas, Sophia;
Gao, Bo;
Wilson, Michelle;
Meniawy, Tarek;
Baron-Hay, Sally;
Briscoe, Karen;
McCarthy, Nicole;
Fountzilas, Christos;
Cervantes, Andres;
Ge, Ruimin;
Wu, John;
Spira, Alexander

Publication type:

Article

Radiogenomics: a key component of precision cancer medicine.

Published in:

British Journal of Cancer, 2023, v. 129, n. 5, p. 741, doi. 10.1038/s41416-023-02317-8

By:

Liu, Zaoqu;
Duan, Tian;
Zhang, Yuyuan;
Weng, Siyuan;
Xu, Hui;
Ren, Yuqing;
Zhang, Zhenyu;
Han, Xinwei

Publication type:

Article

Prognostic benefit of TILs independent of clinicopathological and molecular factors.

Published in:

2023

By:

Brummel, Koen;
Eerkens, Anneke L.;
de Bruyn, Marco;
Nijman, Hans W.

Publication type:

Letter

Immunohistochemical characterisation of the immune landscape in primary uveal melanoma and liver metastases.

Published in:

British Journal of Cancer, 2023, v. 129, n. 5, p. 772, doi. 10.1038/s41416-023-02331-w

By:

Mariani, Pascale;
Torossian, Nouritza;
van Laere, Steven;
Vermeulen, Peter;
de Koning, Leanne;
Roman-Roman, Sergio;
Lantz, Olivier;
Rodrigues, Manuel;
Stern, Marc-Henri;
Gardrat, Sophie;
Lesage, Laetitia;
Champenois, Gabriel;
Nicolas, André;
Matet, Alexandre;
Cassoux, Nathalie;
Servois, Vincent;
Romano, Emanuela;
Piperno-Neumann, Sophie;
Lugassy, Claire;
Barnhill, Raymond

Publication type:

Article